Venture capital fundraising by biopharmaceutical firms in the second quarter was a mixed bag, according to Venture Monitor data from Pitchbook and the National Venture Capital Association (NVCA), wh
Who: Ginkgo BioWorks/Persephone Biosciences What: Synthetic biology specialist Ginkgo inked its third biotech collaboration of 2022, with a partnership to help Persephone develop and deliver novel